W. Kwak, T. Moon, C. Lin, H. Rhyn, H. Jung, E. Lee, D. Kwon, K. Son, H. Kim, S. Kang, M. Murakami, I. Kudo and H. Chang, “Papyriflavolol A from Broussonetia papyrfera Inhibits the Passive Cutaneous Anaphylaxis Reaction and Has a Secretory Phospholipase A2 Inhibitory Activity,” Biological and Pharmaceutical Bulletin, Vol. 26, 2003, pp. 299-302. doi:10.1248/bpb.26.299

has been cited by the following article:

• TITLE: Mugwort (Artemisia vulgaris, Artemisia douglasiana, Artemisia argyi) in the Treatment of Menopause, Premenstrual Syndrome, Dysmenorrhea and Attention Deficit Hyperactivity Disorder

  AUTHORS: James David Adams, Cecilia Garcia, Garima Garg

  KEYWORDS: Mugwort; Artemisia Vulgaris; Artemisia Argyi; Artemisia Douglasiana; Menopause; Attention Deficit Hyperactivity Disorder

  JOURNAL NAME: Chinese Medicine, Vol.3 No.3, September 25, 2012

  ABSTRACT: Mugwort has many traditional uses around the world. The Chumash Indians of California use it to treat imbalances that women may suffer such as premenstrual syndrome, dysmenorrhea and menopausal symptoms. The plant contains a sesquiterpene that appears to work through a serotonergic mechanism and may be beneficial for women. Mugwort therapy is safer for menopausal women than hormone replacement therapy. Children affected by attention deficit hyperactivity disorder benefit from mugwort therapy. There is no doubt that mugwort therapy is safer for these children than methylphenidate or amphetamine.